Stock analysts at SVB Leerink initiated coverage on shares of XOMA (NASDAQ:XOMA – Get Free Report) in a research report issued on Monday, Briefing.com reports. The firm set an “outperform” rating and a $40.00 price target on the biotechnology company’s stock. SVB Leerink’s price target points to a potential upside of 57.42% from the company’s […]